The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bridgen John since 2007.
The trader's CIK number is 1272539.
At the time of the last reporting, Bridgen John was the VP, Strategy for PD of Inverness Medical Innovations Inc. (stock ticker symbol IMA).
Also see all insider trading activities at Inverness Medical Innovations Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALR | 0 | $0 | 0 | $0 | 13,163 | $0 |
| 2016 | ALR | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2015 | ALR | 0 | $0 | 55,064 | $2,751,669 | 60,064 | $2,054,777 |
| 2014 | ALR | 0 | $0 | 50,000 | $1,853,400 | 50,000 | $1,212,500 |
| 2013 | ALR | 0 | $0 | 0 | $0 | 6,664 | $145,141 |
| 2012 | ALR | 0 | $0 | 36,570 | $820,227 | 36,570 | $429,695 |
| 2007 | ALR | 0 | $0 | 13,430 | $794,787 | 13,430 | $157,802 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-08-31 | ALR | Option Ex | 5,000 | .00 | 0 |
| 2017-02-16 | ALR | Option Ex | 8,163 | .00 | 0 |
| 2016-09-09 | ALR | Option Ex | 5,000 | .00 | 0 |
| 2015-08-31 | ALR | Option Ex | 5,000 | .00 | 0 |
| 2015-06-01 | ALR | Option Ex | 7,500 | 26.06 | 195,450 |
| 2015-06-01 | ALR | Sale | 7,500 | 51.19 | 383,932 |
| 2015-05-29 | ALR | Option Ex | 22,564 | 35.58 | 802,827 |
| 2015-05-29 | ALR | Sale | 22,564 | 51.16 | 1,154,487 |
| 2015-03-17 | ALR | Option Ex | 25,000 | 42.26 | 1,056,500 |
| 2015-03-17 | ALR | Sale | 25,000 | 48.53 | 1,213,250 |
| 2014-12-11 | ALR | Option Ex | 50,000 | 24.25 | 1,212,500 |
| 2014-12-11 | ALR | Sale | 50,000 | 37.07 | 1,853,400 |
| 2013-12-12 | ALR | Option Ex | 6,664 | 21.78 | 145,141 |
| 2012-08-07 | ALR | Option Ex | 11,721 | 11.75 | 137,721 |
| 2012-08-07 | ALR | Sale | 11,721 | 18.96 | 222,218 |
| 2012-07-19 | ALR | Option Ex | 4,752 | 11.75 | 55,836 |
| 2012-07-19 | ALR | Sale | 4,752 | 20.00 | 95,040 |
| 2012-04-26 | ALR | Option Ex | 3,486 | 11.75 | 40,960 |
| 2010-04-26 | ALR | Sale | 3,486 | 25.00 | 87,150 |
| 2012-03-07 | ALR | Sale | 4,357 | 25.00 | 108,925 |
| 2012-03-07 | ALR | Option Ex | 4,357 | 11.75 | 51,194 |
| 2012-02-07 | ALR | Option Ex | 5,446 | 11.75 | 63,990 |
| 2012-02-07 | ALR | Sale | 5,446 | 25.10 | 136,694 |
| 2012-02-02 | ALR | Option Ex | 6,808 | 11.75 | 79,994 |
| 2012-02-02 | ALR | Sale | 6,808 | 25.00 | 170,200 |
| 2007-11-20 | IMA | Sale | 13,430 | 59.18 | 794,787 |
| 2007-11-20 | IMA | Option Ex | 13,430 | 11.75 | 157,802 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bridgen John (VP, Strategy for PD of Inverness Medical Innovations Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.